Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.
Saved in:
| Title: | Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers. |
|---|---|
| Authors: | Jahn, A.1,2,3,4 (AUTHOR), Rump, A.1,2,3,4 (AUTHOR), Widmann, T.J.1,2,3,4 (AUTHOR), Heining, C.2,4,5 (AUTHOR), Horak, P.6,7 (AUTHOR), Hutter, B.8,9 (AUTHOR), Paramasivam, N.8 (AUTHOR), Uhrig, S.8,9 (AUTHOR), Gieldon, L.10 (AUTHOR), Drukewitz, S.2,11 (AUTHOR), Kübler, A.1,4 (AUTHOR), Bermudez, M.1,4 (AUTHOR), Hackmann, K.1,4 (AUTHOR), Porrmann, J.1,4 (AUTHOR), Wagner, J.1,4 (AUTHOR), Arlt, M.1,4 (AUTHOR), Franke, M.1,4 (AUTHOR), Fischer, J.1,4 (AUTHOR), Kowalzyk, Z.1,4 (AUTHOR), William, D.1,2,3,4,11 (AUTHOR) |
| Source: | Annals of Oncology. Nov2022, Vol. 33 Issue 11, p1186-1199. 14p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.07.008 |
